I kept my position but unfortunately did not add below $16. Do have some dry powder but already my biggest holding and waiting for some good news on Omidiria. May have to pay up a bit more for shares if news is good and I wait.
at least I don't whine, rip the CEO and #$%$ my pants everytime the stock goes down. sold some at 20, but still have a large amount basis of $5. if that's clueless, then sign me up.
I have owned it since May of 2013 (check the posts) and you come across as someone that thinks they are some bigshot. Then when the stock dips you start whining like a little girl and telling people they don't know what they are talking about.
why don't you get a life. every time you post it's negative and worthless. you are the same clown that has been whining and acting like a little girl. man up or just sell you shares
I don't think that's what triggered it either. Similar to those moronic Zacks ratings. Still worried that other bad news leaked and like you said bigger holder slowly sold out over past week.
and to think you could have bought all you wanted at $5, you were on these boards at the time. talk about a miss. 4 bagger - WOW
We are in inning 2 of a 9 inning game with this company. If you are willing ot ride the ups downs over the next 3-5yrs you should be rewarded. If you are looking for a quick profit you will likely be disappointed.
I don't think the CEO would do it at this point. This guys goal is for OMER to be the biggest biotech in the Northwest/Seattle area. He has referenced Immunex in the past, which was eventually bought out by Amgen in 2001 for 16B.
I don't recall hearing anything on the trials restarting?
he definitely was working to put a hole in omidria, could be a short or also just doing his job. many of these buy side analysts are rubber stamps for the companies they follow. ceo is very good, well spoken, knowledgable etc